Neuropeptide hormone studied for social bonding, trust behavior, sexual arousal, anxiety reduction, and cardiovascular protective effects beyond reproductive function.
1–6 minutes (plasma); CNS effects longer via nasal route
SKUs
1
Evidence
High Evidence
Oxytocin is a hormone and neuropeptide naturally produced in the brain that plays important roles in social bonding, trust, maternal behavior, and uterine contractions during labor. It is FDA-approved as an injectable medication for labor induction and postpartum hemorrhage. Research has extensively studied its potential roles in social cognition, autism, anxiety, eating disorders, and metabolic health.
Social Cognition and Autism Research
A significant body of research has examined intranasal oxytocin for improving social behavior in autism spectrum disorder. Meta-analyses of trials show modest improvements in social cognition in some populations, though effects are inconsistent and magnitude of benefit has been debated. More recent larger trials have produced mixed results.
Anxiety and Stress Research
Oxytocin has been studied for its anxiolytic effects in stress contexts. Research shows it reduces cortisol response to social stress and reduces activity in the amygdala (the fear center). Context matters significantly — effects are modulated by social environment and individual differences.
Metabolic and Appetite Research
More recent research has examined oxytocin for metabolic effects. Receptors for oxytocin exist in the hypothalamus and peripheral metabolic tissues. Some human studies have shown that intranasal oxytocin reduces food intake and body weight, particularly in overweight individuals.
Labor and Delivery
Oxytocin (Pitocin) is an FDA-approved intravenous medication used to initiate or augment labor and prevent postpartum hemorrhage by stimulating uterine contractions. This is its most well-established clinical use.
FDA-approved for labor induction and postpartum hemorrhage with well-established clinical use.
Intranasal oxytocin shows modest and inconsistent effects on social cognition in autism trials.
Reduces cortisol response to social stress and amygdala reactivity in research studies.
Some human trials show reductions in food intake and body weight with intranasal administration.
Effects are highly context-dependent and influenced by individual characteristics.
The research on intranasal oxytocin for social cognition in autism has been inconsistent. A large NIH-funded trial found no significant benefit in children with autism, which dampened earlier enthusiasm. Intranasal delivery produces highly variable blood and brain levels, making dose-response relationships difficult to establish. Oxytocin effects are strongly context-dependent. Intranasal oxytocin for non-obstetric uses is not FDA-approved.
Oxytocin acts on receptors throughout the brain and body, with particularly important effects in regions involved in social behavior, reward, and stress response. In the brain, it generally dampens the stress response by reducing activity in the amygdala — the area that triggers fear and social wariness — and by reinforcing the sense of safety and connection in social contexts. Peripherally, it plays roles in smooth muscle contraction (which is why it induces uterine contractions), gut function, and metabolic regulation. Because it works in context — meaning its effects depend on the social and environmental situation — it is more complex than compounds that simply raise or lower a single hormone level.
IV oxytocin for labor and delivery is well-characterized and safely used under medical supervision. Intranasal oxytocin is generally well-tolerated in research studies. Side effects in trials have been mild and infrequent. Concerns have been raised about potential anxiety-promoting effects in some contexts (oxytocin does not universally reduce anxiety) and about potential effects on early social development with chronic use in children. It is not FDA-approved for non-obstetric uses.
High Evidence
This compound has been studied in multiple large randomized controlled trials with human subjects. The evidence base is strong and consistent across independent research groups.
Published Research Ranges
24–40 IU intranasal; 0.2–0.4mg IM in research
Research Context Only: These are ranges reported in published scientific studies for educational reference. They are not dosing recommendations. This is not medical advice. Always consult a qualified healthcare professional.
Sources listed here are from the platform research library. All links open the original publication. No citations are generated by AI.
Intranasal Oxytocin and Social Cognition: A Review of the Clinical Evidence
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
Research Education Only: This profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions.
We use cookies to enhance your research experience and analyze platform usage. By continuing, you agree to our Cookie Policy.